Renamed: Extracting DMF Facilities from unstructured documents Previously: DMF (Drug Master File) Facilities
Description
FDA receives Drug Master File (DMF) submissions containing valuable information about manufacturing facilities, but this data exists in various document formats that require manual review to compile comprehensive facility information.
Detailed example
Support information extraction from unstructured documents
AI / analytics pattern
Natural Language Processing: AI that processes, interprets, and shares information in human language.
Automation level / stage
c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
Expected benefit
Extracts facility references from Type II (Drug Substance) DMF manufacturing submissions (i.e., DMF123456 discloses that it uses Facility X for manufacturing and Facility Y for stability testing). These DMF submissions may include structured documents (3938 form) or unstructured documents (electronic Common Technical Document module 3), enabling more comprehensive oversight of the drug supply chain.
Controls / human review
ATO: Yes; PIA: Not published
Data needed
Applicant submissions